The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Progression of medullary thyroid carcinoma: assessment with calcitonin and carcinoembryonic antigen doubling times
Abstract
Objective: The progression of medullary thyroid cancer is difficult to assess with imaging modalities; we studied the interest of calcitonin and carcinoembryonic antigen (CEA) doubling times and of Ki-67 labeling and mitotic index (MI). Patients and methods: Fifty-five consecutive medullary thyroid carcinoma (MTC) patients with elevated calcitonin levels underwent repeated imaging studies in order to assess tumor burden and progression status. We looked for relationships between tumor burden and levels of calcitonin and CEA and between progression status according to the response evaluation criteria in solid tumors (RECIST) and calcitonin and CEA doubling times, and Ki-67 labeling and MI. Results: The calcitonin and CEA levels were correlated with tumor burden. Ten patients with calcitonin levels below 816 pg/ml had no imaged tumor foci. Among the 45 patients with imaged tumor foci, 19 had stable disease and 26 had progressive disease, according to the RECIST. The calcitonin and CEA doubling times were strongly related to disease progression, with very few overlaps: 94% of patients with doubling times shorter than 25 months had progressive disease and 86% of patients with doubling times longer than 24 months had stable disease. Ki-67 labeling and MI were not significantly associated with disease progression. Conclusion: For MTC patients, the doubling times of both calcitonin and CEA are efficient tools for assessing tumor progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
New Guidelines to Evaluate the Response to Treatment in Solid Tumors
Therasse, P., Arbuck, S. G., Eisenhauer, E. A., Wanders, J., Kaplan, R. S., Rubinstein, L., Verweij, J., Van Glabbeke, M., van Oosterom, A. T., Christian, M. C., et al. (2000) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/92.3.205 · Cited by 15,660
de Azambuja, E., Cardoso, F., de Castro, G., Colozza, M., Mano, M. S., Durbecq, V, Sotiriou, C., Larsimont, D., Piccart-Gebhart, M. J., & Paesmans, M. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603756 · Cited by 959
Observations on growth rates of human tumors.
Collins, V. P., Loeffler, R. K., & Tivey, H. (1956) · PubMed · Cited by 758
Robbins, R. J., Wan, Q., Grewal, R. K., Reibke, R., Gonen, M., Strauss, H. W., Tuttle, R. M., Drucker, W., & Larson, S. M. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1534 · Cited by 587
Vansteenkiste, J. F., Stroobants, S. G., Dupont, P. J., De Leyn, P. R., Verbeken, E. K., Deneffe, G. J., Mortelmans, L. A., & Demedts, M. G. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.10.3201 · Cited by 439
Barbet, J., Campion, L., Kraeber-Bodéré, F., & Chatal, J.-F. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0044 · Cited by 407
Downey, R. J., Akhurst, T., Gonen, M., Vincent, A., Bains, M. S., Larson, S., & Rusch, V. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.11.109 · Cited by 358
Cohen, R. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.2.919 · Cited by 274
Imaging Medullary Thyroid Carcinoma with Persistent Elevated Calcitonin Levels
Giraudet, A. L., Vanel, D., Leboulleux, S., Aupérin, A., Dromain, C., Chami, L., Ny Tovo, N., Lumbroso, J., Lassau, N., Bonniaud, G., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1211 · Cited by 265
Self-citationNishino, M., Pusztaszeri, M. P., & Pitman, M. B. (2018) · The Bethesda System for Reporting Thyroid Cytopathology · doi:10.1007/978-3-319-60570-8_9 · Cited by 234
FDG-PET Prediction of Head and Neck Squamous Cell Cancer Outcomes
Schwartz, D. L., Rajendran, J., Yueh, B., Coltrera, M. D., LeBlanc, M., Eary, J., & Krohn, K. (2004) · Archives of Otolaryngology–Head & Neck Surgery · doi:10.1001/archotol.130.12.1361 · Cited by 190
Ong, S. C., Schoder, H., Patel, S. G., Tabangay-Lim, I. M., Doddamane, I., Gonen, M., Shaha, A. R., Tuttle, R. M., Shah, J. P., & Larson, S. M. (2007) · Journal of Nuclear Medicine · doi:10.2967/jnumed.106.036681 · Cited by 172
Busnardo, B., Girelli, M. E., Simioni, N., Nacamulli, D., & Busetto, E. (1984) · Cancer · doi:10.1002/1097-0142(19840115)53:2<278::aid-cncr2820530216>3.0.co;2-z · Cited by 159
Pellegriti, G., Leboulleux, S., Baudin, É., Bellon, N., Scollo, C., Travagli, J. P., & Schlumberger, M. J. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600930 · Cited by 146
Self-citationMiyauchi, A., Onishi, T., Morimoto, S., Takai, S., Matsuzuka, F., Kuma, K., Maeda, M., & Kumahara, Y. (1984) · Annals of Surgery · doi:10.1097/00000658-198404000-00014 · Cited by 118
Sperti, C., Pasquali, C., Chierichetti, F., Ferronato, A., Decet, G., & Pedrazzoli, S. (2003) · Journal of Gastrointestinal Surgery · doi:10.1016/j.gassur.2003.09.002 · Cited by 114
The role of PET in follow-up of patients treated for differentiated epithelial thyroid cancers
Leboulleux, S., Schroeder, P. R., Schlumberger, M. J., & Ladenson, P. W. (2007) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0402 · Cited by 109
Self-citationKatoh, R., Bray, C. E., Suzuki, K., Komiyama, A., Hemmi, A., Kawaoi, A., Oyama, T., Sugai, T., & Sasou, S. (1995) · Human Pathology · doi:10.1016/0046-8177(95)90029-2 · Cited by 109
Bertolini, F., Bengala, C., Losi, L., Pagano, M., Iachetta, F., Dealis, C., Jovic, G., Depenni, R., Zironi, S., Falchi, A., et al. (2007) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.02.018 · Cited by 107
Medullary thyroid carcinoma.Importance of serial serum calcitonin measurement
Stepanas, A. V., Samaan, N. A., Hill, C., & Hickey, R. C. (1979) · Cancer · Cited by 107
The Ki67 index a prognostic marker in medullary thyroid carcinoma
Tisell, L. E., Odén, A., Muth, A., Altiparmak, G., Mölne, J., Ahlman, H. K., & Nilsson, O. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601453 · Cited by 84
Drug Insight: small-molecule inhibitors of protein kinases in the treatment of thyroid cancer
Santoro, M., & Carlomagno, F. (2006) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0073 · Cited by 79
Caribbean T-cell lymphoma/leukemia
Swerdlow, S. H., Habeshaw, J. A., Rohatiner, A. Z. S., Lister, T. A., & Stansfeld, A. G. (1984) · Cancer · doi:10.1002/1097-0142(1984)54:4<657::aid-cncr2820540412>3.0.co;2-v · Cited by 49
Cited by
Wells, S. A., Asa, S. L., Dralle, H., Elisei, R., Evans, D. B., Gagel, R. F., Lee, N., Machens, A., Moley, J. F., Pacini, F., et al. (2015) · Thyroid · doi:10.1089/thy.2014.0335 · Cited by 2,444
Self-citationMedullary Thyroid Cancer: Management Guidelines of the American Thyroid Association
Kloos (Chair), R. T., Eng, C., Evans, D. B., Francis, G. L., Gagel, R. F., Gharib, H., Moley, J. F., Pacini, F., Ringel, M. D., Schlumberger, M., et al. (2009) · Thyroid · doi:10.1089/thy.2008.0403 · Cited by 1,357
Self-citationCabozantinib in Progressive Medullary Thyroid Cancer
Elisei, R., Schlumberger, M. J., Müller, S. P., Schöffski, P., Brose, M. S., Shah, M. H., Licitra, L., Jarzab, B., Medvedev, V., Kreissl, M. C., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.48.4659 · Cited by 1,217
Self-citationThyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Filetti, S., Durante, C., Hartl, D., Leboulleux, S., Locati, L. D., Newbold, K., Papotti, M. G., & Berruti, A. (2019) · Annals of Oncology · doi:10.1093/annonc/mdz400 · Cited by 1,200
Self-citationPatel, K. N., Yip, L., Lubitz, C. C., Grubbs, E. G., Miller, B. S., Shen, W., Angelos, P., Chen, H., Doherty, G. M., Fahey, T. J., et al. (2020) · Annals of Surgery · doi:10.1097/sla.0000000000003580 · Cited by 541
Metadata
- Authors
- Laure Giraudet, A., Al Ghulzan, A., Aupérin, A., Leboulleux, S., Chehboun, A., Troalen, F., Dromain, C., Lumbroso, J., Baudin, E., & Schlumberger, M.
- Venue
- European Journal of Endocrinology
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-02
- Volume
- 158
- Issue
- 2
- Pages
- 239-246
- ISSN
- 0804-4643 (ISSN-L)
- 1479-683X
- OpenAlex
- W2164124089
- Cited by
- 272
- References
- 23
- FWCI
- 11.55
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.